Research graph
References from Assessment of Treatment Response in Patients With Scleromyxedema by the Double Modified Rodnan Skin Score. Local targets link to admitted publications; unresolved targets remain external evidence.
Scleromyxedema: A Multicenter Study of Characteristics, Comorbidities, Course, and Therapy in 30 Patients
10.1016/j.jaad.2013.01.007 · 2013 · External reference
Updated Classification of Papular Mucinosis, Lichen Myxedematosus, and Scleromyxedema
10.1067/mjd.2001.111630 · 2001 · External reference
Clinical and Molecular Phenotyping in Scleromyxedema Pretreatment and Posttreatment With Intravenous Immunoglobulin
10.1002/acr.23908 · 2020 · External reference
High‐Dose Intravenous Immunoglobulin Therapy for Scleromyxoedema: A Prospective Open‐Label Clinical Trial Using an Objective Score of Clinical Evaluation System
10.1111/jdv.14244 · 2017 · External reference
Course of the Modified Rodnan Skin Thickness Score in Systemic Sclerosis Clinical Trials: Analysis of Three Large Multicenter, Double‐Blind, Randomized Controlled Trials
10.1002/art.24681 · 2009 · External reference
Standardization of the Modified Rodnan Skin Score for Use in Clinical Trials of Systemic Sclerosis
10.5301/jsrd.5000231 · 2017 · External reference
Scleromyxedema
10.1111/ddg.14319 · 2020 · External reference
Europäische Leitlinien (S1) für die Verwendung von hoch dosierten intravenösen Immunglobulinen in der Dermatologie
10.1007/s00105-020-04610-6 · 2020 · External reference
High‐Dose Intravenous Immunoglobulin in Skin Autoimmune Disease
10.3389/fimmu.2019.01090 · 2019 · External reference
Treatment of a Complex Case of Scleromyxedema Using a Novel Intravenous Immunoglobulin Preparation
10.1159/000540519 · 2024 · External reference
Scleromyxoedema: Clinical Follow‐Up After Successful Treatment With High‐Dose Immunoglobulins Reveals Different Long‐Term Outcomes
10.2340/00015555-1299 · 2012 · External reference
Treatment of Scleromyxedema and the Dermatoneuro Syndrome With Intravenous Immunoglobulin
10.1016/j.jaad.2008.11.013 · 2009 · External reference
Dermato‐neurologisches Syndrom – eine akute und lebensbedrohliche Komplikation des Skleromyxödems Arndt‐Gottron
10.1007/s00105-023-05159-w · 2023 · External reference
Scleromyxoedema: Treatment of Cutaneous and Systemic Manifestations With High‐Dose Intravenous Immunoglobulin
10.1111/j.1365-2133.2003.05682.x · 2003 · External reference
Repeated Teaching Courses of the Modified Rodnan Skin Score in Systemic Sclerosis
2010 · External reference
Cutaneous Manifestations of Scleroderma and Scleroderma‐Like Disorders: A Comprehensive Review
10.1007/s12016-017-8625-4 · 2017 · External reference
